The prospect of endoscopic submucosal dissection for early anal canal squamous cell carcinoma

被引：10

作者：

Ito T. ^{[1
]}

Morita S. ^{[1
]}

Shimeno N. ^{[1
]}

Uehara K. ^{[2
]}

Imai Y. ^{[2
]}

Inokuma T. ^{[1
]}

机构：

[1] Department of Gastroenterology, Kobe City Medical Center General Hospital, Minatojimaminami-machi 2-1-1, Chuo-ku, Kobe-Shi, 650-0047, Hyogo

[2] Department of Clinical Pathology, Kobe City Medical Center General Hospital, Minatojimaminami-machi 2-1-1, Chuo-ku, Kobe-Shi, 650-0047, Hyogo

来源：

Clinical Journal of Gastroenterology | 2016年 / 9卷 / 6期

关键词：

Anal canal cancer; Endoscopic submucosal dissection (ESD); Squamous cell carcinoma;

D O I：

10.1007/s12328-016-0690-3

中图分类号：

学科分类号：

摘要：

Squamous cell carcinoma (SCC) of the anal canal is seldom diagnosed at an early stage. Chemoradiation therapy is a standard in Europe and the United States, though in squamous cell carcinoma there is no evidence-based therapy. In Japan, endoscopic submucosal dissection (ESD) is the standard minimally invasive treatment for early stage cancer of the digestive tract, including the colorectum. Therefore, if the lesion is diagnosed at an early stage, ESD may be selected for anal canal lesions. We experienced two cases of early stage anal canal cancer in which the diagnosis and the extent of the lesions were confirmed using magnifying endoscopy with narrow-band imaging (NBI), as well as performing ESD. Pathological examination showed the resected specimen to be SCC in situ; the horizontal and vertical margins were free of tumor; and in one case there was no lymphovascular invasion. In the other case it showed the tumor was contained within the epithelium; horizontal and vertical margins were free of tumor; The follow-up period is not long enough to assert that ESD for anal canal squamous cell carcinoma may be an option of minimally invasive therapy. However, if there is a possibility of lymphatic invasion as in one of our cases, we need to give serious consideration to ESD for these lesions, and careful follow-up is necessary even if the lesion is in situ. © 2016, Japanese Society of Gastroenterology.

引用

页码：384 / 388

页数：4

共 11 条

[1]

Joseph D.A., Miller J.W., Wu X., Et al., Understanding the burden of human papillomavirus-associated anal cancers in the US, Cancer, 113, pp. 2892-2900, (2008)

[2]

UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin, Lancet, 348, pp. 1049-1054, (1997)

[3]

Yoshida T., Inoue H., Usui S., Et al., Narrow-band imaging system with magnifying endoscopy for superficial esophagus lesions, Gastrointest Endosc, 59, 2, pp. 288-295, (2004)

[4]

Inoue H., Magnification endoscopy in the esophagus and stomach, Dig Endosc, 13, pp. S40-S41, (2001)

[5]

Oono Y., Fu K., Nakamura H., Et al., Narrowband imaging colonoscopy with a transparent hood for diagnosis of a squamous cell carcinoma in situ in the anal, Endoscopy, 42, pp. E183-E184, (2010)

[6]

Tsuji S., Doyama H., Yamada S., Et al., Endoscopic submucosal dissection of a squamous cell carcinoma in situ in the anal canal diagnosed by magnifying endoscopy with narrow-band imaging, Clin J Gastroenterol, 7, 3, pp. 233-237, (2014)

[7]

Clark M.A., Hartley A., Geh J.I., Cancer of the anal canal, Lancet Oncol, 5, pp. 149-157, (2004)

[8]

Gerard J.P., Chapet O., Samiei F., Et al., Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature, Cancer, 92, pp. 77-84, (2001)

[9]

Repici A., Hassan C., Paula D., Et al., Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: systematic review, Endoscopy, 44, pp. 137-150, (2012)

[10]

Tsuji S., Doyama H., Yamada S., Et al., Endoscopic submucoal dissection of a squamous cell carcinoma in situ in the anal canal diagnosed by magnifying endoscopy with narrow-band imaging, Clin J Gastroenterol, 7, 3, pp. 233-237, (2014)

← 1 2 →